See today's BioWorld Science
To read the full story, subscribe or sign in.
Drug design, drug delivery & technologies

Orbis to use Vivtex platform for gut permeability screening

Sep. 18, 2024
Orbis Medicines SA has announced a research collaboration and option to an exclusive license with Vivtex Corp.
BioWorld Science Deals and M&A Drug design, drug delivery and technologies Collaboration Gastrointestinal Small molecule